Marker Therapeutics Inc (MRKR)

[Sugarshaker]

Looks like Imfinzi is on a clinical hold hope we are not next,

Advaxis Inc. ADXS, -17.62% shares sank in the extended session Monday after the biotech company's cancer-drug study was placed on hold following the death of a patient in the study. Advaxis shares fell 24% after hours, following an initial halting. Shares finished up 0.5% at $2.21 in regular trading Monday. The clinical hold affects the company's clinical trial for the combination of the drugs Imfinzi and axalimogene filolisbac for the treatment of human papillomavirus-associated cervical cancer and HPV-associated head and neck cancer. "Enrollment and further dosing are on hold in this trial while the company, its partner and the [Food and Drug Administration] work closely with the site investigator to review this event in detail and to resolve this clinical hold," the company said in a statement.